Showing 261 - 280 results of 1,474 for search 'obstructive changes', query time: 0.10s Refine Results
  1. 261

    A Wearable Functional Near-Infrared Spectroscopy (fNIRS) System for Obstructive Sleep Apnea Assessment by Xude Huang, Jinbu Tang, Jingchun Luo, Feng Shu, Chen Chen, Wei Chen

    Published 2023-01-01
    “…Obstructive sleep apnea (OSA), one of the most common sleep-related breathing disorders, contributes as a potentially life-threatening disease. …”
    Get full text
    Article
  2. 262

    Serum sphingomyelin levels define oxyhemoglobin desaturation-related metabolic threshold in symptomatic obstructive sleep apnea by Ott Kiens, Egon Taalberg, Viktoria Ivanova, Ketlin Veeväli, Triin Laurits, Ragne Tamm, Aigar Ottas, Kalle Kilk, Ursel Soomets, Alan Altraja

    Published 2025-04-01
    “…Abstract Hypoxia is a contributing factor for the morbidity and mortality in patients with obstructive sleep apnea (OSA). We aimed at identifying the percentage of sleep time with oxyhemoglobin desaturation below 90% (Tc90%) breakpoint from which the most significant changes occur in systemic metabolome of patients with OSA. …”
    Get full text
    Article
  3. 263

    Uncommon cause of large bowel obstruction in a pediatric patient: A case of phytobezoar induced by peas by Kinfemicheal Tilahu Yigzaw, Dawit Aysheshim Mulualem, Bethlehem Aliye Asfaw, Melkamu Temesgen Moges, Biniyam Alebachew Tegegne, Meseret Hussien Shibesh, Mesfin Tesera Wassie

    Published 2025-05-01
    “…There is no report of case causing large bowel obstruction due to peas and up to our best, it is the first case to be documented of such a large obstruction resulting from peas. …”
    Get full text
    Article
  4. 264

    Clinical characteristics of the respiratory and cardiovascular systems in patients with combination of chronic obstructive pulmonary disease and heart failure by I. I. Vyshnyvetskyy, L. S. Kholopov, V. O. Batashova-Halynska

    Published 2017-06-01
    “…In particular, the presence of CHF, especially with impaired systolic function significantly impair indicators such as incidence of cardiac arrhythmias and signs of ischemia on the ECG, NT-proBNP levels, prevalence of concentric, eccentric hypertrophy and concentric LV remodeling and diastolic dysfunction type "relaxation disorder", and incidence of a-wave absence during assessment of motion of the rear pulmonary artery valve wall. Listed changes as well as some of the tendencies that have not reached a certain level of significance, indicate that patients with COPD and concomitant CHF, especially with impaired systolic function, worsens general clinical parameters (breath rate, systolic blood pressure, heart rate, frequency arrhythmias and myocardial ischemia on ECG); laboratory levels of hemoglobin, hematocrit, cholesterol, glomerular filtration rate; spirometric indicators of bronchial obstruction (FEV1, FVC, instant volume expiratory flow rates); echocardiographic indicators suggest the deterioration of the heart geometry (increasing of myocardial mass index, indexes of LV end-systolic and end-diastolic volumes, increased frequency of all variants of LV pathological remodeling detection, RV wall thickness, the ratio of RV/LV) diastolic function impairment (increased frequency of all types diastolic dysfunction detection); development of pulmonary hypertension (increasing of the maximum flow velocity, pressure gradient, and the systolic pressure in the pulmonary artery, the frequency of detection of the absence of a-wave). …”
    Get full text
    Article
  5. 265
  6. 266
  7. 267

    Laryngeal and pleural ultrasound and acoustic radiation force impulse elastography in dogs with brachycephalic obstructive airway syndrome by Ariadne Rein, Andréia Coutinho Facin, Isabella de Almeida Fabris, Bruna Bressianini Lima, Beatriz Gasser, Luiz Paulo Nogueira Aires, Ricardo Andres Ramirez Uscategui, Marcus Antônio Rossi Feliciano, Paola Castro Moraes

    Published 2025-06-01
    “…The results suggest a secondary change in inspiratory effort at the tissue level of the pleura in dogs clinically affected by BOAS, which can be identified by B-mode ultrasound and elastography methods; however, it was not possible to diagnose changes in the arytenoid cartilage.…”
    Get full text
    Article
  8. 268

    Role of VDAC1 in hepatocyte apoptosis during acute liver injury in rats induced by obstructive jaundice by Jinshan Liu, Jinlong Hu, Hongyu Xu, Liang Yan, Jiaming Yao, Baoqiang Cao

    Published 2025-01-01
    “…H&E and TEM were employed to observe pathological changes in the liver tissues. Flow cytometry was used to measure the hepatocyte apoptosis. …”
    Get full text
    Article
  9. 269

    Impact of smoking status on the efficacy of inhaled corticosteroids in chronic obstructive pulmonary disease: a systematic review by Roger Knaggs, Kimberley Sonnex, Hanna Alleemudder

    Published 2020-04-01
    “…Smokers using ICS had mixed results in FEV1 change: −8 mL to +77 mL in comparison to ex-smokers. …”
    Get full text
    Article
  10. 270

    Targeting Trefoil Factor Family 3 in Obstructive Airway Diseases: A Computational Approach to Novel Therapeutics by Alireza Shahriary, Mohsen Sisakht, Masoud Arabfard, Esmaeil Behmard, Ali Najafi

    Published 2025-03-01
    “…Background: Airway remodeling, a hallmark of chronic obstructive pulmonary disease (COPD) and mustard lung disease, is influenced by the Trefoil Factor 3 (TFF3). …”
    Get full text
    Article
  11. 271

    Keystone bacteria dynamics in chronic obstructive pulmonary disease (COPD): Towards differential diagnosis and probiotic candidates by Azadeh KavianFar, Hamidreza Taherkhani, Hossein Lanjanian, Sargol Aminnezhad, Ali Ahmadi, Sadegh Azimzadeh, Ali Masoudi-Nejad

    Published 2025-02-01
    “…Preventing exacerbations in Chronic Obstructive Pulmonary Disease (COPD) is crucial due to the high mortality rate and the associated costs of hospitalization for patients during exacerbations. …”
    Get full text
    Article
  12. 272

    The influence of systemic inflammatory markers on the development of obstetrical complications in pregnant women with chronic obstructive pulmonary disease by S. M. Heriak, O. I. Oleksiak

    Published 2023-03-01
    “…The increasing prevalence of chronic obstructive pulmonary disease (COPD) among the female half of the population is the reason for the increased interest of scientists in the course of COPD and its impact on pregnant women. …”
    Get full text
    Article
  13. 273

    Clinical variants, outcomes and prognosis of hypertrophic non-obstructive cardiomyopathy: results of long-term follow-up by D. V. Bogdanov, I. I. Shaposhnik

    Published 2019-11-01
    “…Based  on the results  of a long-term  follow-up, to determine  the clinical variants  of  hypertrophic  non-obstructive cardiomyopathy  (HNOCM) and  develop criteria for the progression of the disease.Material and methods. …”
    Get full text
    Article
  14. 274

    Characteristics of neutrophilic granulocytes of peripheral blood in patients with mechanical jaundice caused by cholangiocarcinoma by O. V. Smirnova, B. G. Gubanov, E. V. Kasparov, M. A. Darenskaya, L. I. Kolesnikova, S. I. Kolesnikov

    Published 2022-03-01
    “…Obstructive jaundice caused by cholangiocarcinoma takes a special place among malignant disorders and surgical pathology in Russia. …”
    Get full text
    Article
  15. 275

    Low-intensive Laser Therapy for Management of Cerebral Dysfunction in Patients with Obstructive Jaundice of Non-tumor Origin by A. P. Vlasov, I. A. Chigakova, D. E. Timoshkin, M. A. Spirina, V. S. Kuznetsov, N. S. Sheyranov, A. V. Rubtsov

    Published 2019-04-01
    “…The complex treatment of obstructive jaundice, which included laser therapy, allowed a relatively rapid recovery of the functional state of the brain to be observed, as evidenced by the shortening of the test time for the tests being studied. …”
    Get full text
    Article
  16. 276

    Obstructive hypertrophic cardiomyopathy: from genetic insights to a multimodal therapeutic approach with mavacamten, aficamten, and beyond by Khadija Sarwer, Saeeda Lashari, Nida Rafaqat, Maher, Abdul Raheem, Muneeb Ur Rehman, Syed Muhammad Iraj Abbas

    Published 2024-12-01
    “…These mutations lead to disrupted sarcomere function, resulting in hypertrophic changes and LVOT obstruction. While genetic heterogeneity is a hallmark of HCM, clinical diagnosis relies heavily on imaging techniques such as Echocardiography and cardiac magnetic resonance imaging to assess the extent of hypertrophy and obstruction. …”
    Get full text
    Article
  17. 277

    Clinical characteristics and outcomes of chronic obstructive pulmonary disease patients with family history of chronic airway disease by Cong Liu, Qing Song, Ya-ting Peng, Wei Cheng, Ling Lin, Tao Li, Xue-shan Li, Yu-qin Zeng, Ai-yuan Zhou, Yan Chen, Shan Cai, Ping Chen

    Published 2025-12-01
    “…Background Chronic Obstructive Pulmonary Disease (COPD) is a heterogeneous condition with different risk factors, including family history. …”
    Get full text
    Article
  18. 278

    Hypoxic Burden and T90% as Predictive Indicators of Cardiovascular Risk and Myocardial Ischemia in Patients with Obstructive Sleep Apnea by Zeng W, Wu S, Liu Z, Yuan L, Chen B, Rong Y

    Published 2025-07-01
    “…Among them, 51.4% demonstrated electrocardiogram changes indicative of myocardial ischemia, and 55.3% had moderate-to-high 10-year ASCVD risk. …”
    Get full text
    Article
  19. 279

    Molecular mechanisms and therapeutic targets of acute exacerbations of chronic obstructive pulmonary disease with Pseudomonas aeruginosa infection by Zhiwei Lin, Shuang Liu, Ke Zhang, Tianyu Feng, Yewei Luo, Yu Liu, Baoqing Sun, Luqian Zhou

    Published 2025-03-01
    “…Abstract Background Chronic Obstructive Pulmonary Disease (COPD) is a leading cause of global mortality, with acute exacerbations of COPD (AECOPD) significantly increasing the disease’s morbidity and mortality. …”
    Get full text
    Article
  20. 280